Multinational pharma majors Hospira and Kowa Company have dragged Aurobindo Pharma to the court on allegations of patent infringement.
Hospira has alleged that Aurobindo’s Abbreviated New Drug Application to make generic dexmedetomidine hydrochloride injection would infringe its patented drug Precedex.
“Of the Livalo patents, through the commercial manufacture, use, sale, offer for sale or importation into the United States of Aurobindo’s pitavastatin drug product or any drug product containing Pitavastatin,” Kowa prayed the court in its petition.
Also Read
BJP manifesto: Narendra Modi is the message
As Maharajas? Express looks to cut prices, it?s king-size life at half rate
Foreign airlines not liable to deduct TDS on navigation charges: SC
Mukesh Ambani is wealthiest Indian cricket team owner, worth $21.2 bn: report
